Report cover image

Melanoma Therapeutics: Global Markets

Publisher BCC Research
Published Nov 17, 2023
Length 131 Pages
SKU # WA18339474

Description

Melanoma Therapeutics: Global Markets



Report Scope:

This study investigates the melanoma treatment market. BCC Research analyzes melanoma treatment based on treatment type, cancer stage and type of therapeutics. BCC determines the current market status in each segment, examines its impact on future needs and presents growth forecasts over the next five years. The report provides a detailed analysis of the market’s drivers, challenges, and opportunities. The report also covers market projections through 2028 and analyzes market share for key market players. In its profiles of key companies, the report provides detailed information about their business segments, financials, product portfolios and recent developments. The report also discusses the market impact of the COVID-19 pandemic, emerging technologies, and new developments, ESG development and investment outlook.

Report Includes:

30 data tables and 18 additional tables

An overview of the global market for melanoma treatment

Analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028

Description of various treatment options such as chemotherapy, surgical resection, immunotherapy, and targeted therapies; and various treatment approaches for the betterment of patient's overall health

A look at the advancements in the genetic profiling of melanocytes and identification of novel molecules that involved in melanoma's development

Information on new potential therapeutic target discovery; and description of novel immune checkpoint inhibitors, adoptive cell therapy and engineered TCR therapy

Coverage of innovation, technological advancements, and the launch of novel products from market players

Detailed analysis of the regulatory framework and policies and product pipeline of the industry, and discussion on ESG challenges in the pharmaceutical industry and ESG practices in the melanoma treatment market

Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis

Comprehensive company profiles of the leading players of the industry, including Amgen, Roche, Merck & Co., Pfizer Inc., BMS, and Novartis AG

Table of Contents

131 Pages
Chapter 1 Introduction
Study Goals and Objectives
Scope of the Report
Reasons for Doing the Study
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market and Technology Background
Introduction
Risk Factors, Causes and Prevention
Symptoms
Pathophysiology and Clinical Subtypes
Prognosis
Epidemiology
Diagnosis
Biopsy
Laboratory Tests
Blood Tests
Imaging Tests
Treatment
Immunotherapy
PD-1 and PD-L1 Inhibitors
CTLA-4 inhibitors
LAG-3 Inhibitors
Interleukin-2 (IL-2, Proleukin)
Virus Therapy
BRAF inhibitors:
MEK Inhibitors
Chapter 4 Market Dynamics
Market Factors
Market Drivers
Increasing Prevalence of Melanoma
Technological Advancements and Product Launches
Strategic Initiatives
Developments in Early Detection Tools
Patient Advocacy Groups and Awareness
Market Restraints
High Cost of Treatment
Stringent Regulations
Resistance to Therapies
Market Opportunities
Chapter 5 Market Breakdown by Type
Overview
Surgery
Wide Excision
Mohs Surgery
Amputation
Lymph Node Dissection
Therapeutics
Therapeutics by Type
Radiation Therapy
Chapter 6 Market Breakdown by Disease Stage
Overview
Localized Disease
Regional Disease
Distant Disease
Chapter 7 Market Breakdown by Region
Overview
North America
Europe
Asia-Pacific
Rest of the World
Chapter 8 Sustainability: An ESG Perspective
Introduction
ESG Challenges in the Pharmaceutical Industry
ESG Practices in the Market for Melanoma Therapeutics
Environmental Initiatives
Social Initiatives
Governance Initiatives
Case Study
BCC Research Viewpoint
Chapter 9 Emerging Technologies/ Developments
Introduction
Novel Immune Checkpoint Inhibitors
Adoptive Cell Therapy
Engineered TCR Therapy
Vaccines
Targeted Therapy
Chapter 10 Regulatory Landscape and Pipeline Analysis
Regulatory Landscape
United States
Europe
Japan
Pipeline Analysis
Chapter 11 Patent Analysis
Patent Review by Year
Patent Review by Country
Patent Review
Chapter 12 Competitive Landscape
Mergers and Acquisitions
Strategic Initiatives
Competitive Analysis
Chapter 13 Company Profiles
AMGEN INC.
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB
ERASCA INC.
F. HOFFMANN-LA ROCHE AG
HUYABIO INTERNATIONAL
IOVANCE BIOTHERAPEUTICS INC.
IO BIOTECH
MERCK & CO. INC.
MODERNA INC.
NOVARTIS AG
PFIZER INC.
REGENERON PHARMACEUTICALS INC.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us